181 related articles for article (PubMed ID: 34014094)
1. Selective Inhibition of DNA Polymerase β by a Covalent Inhibitor.
Yuhas SC; Laverty DJ; Lee H; Majumdar A; Greenberg MM
J Am Chem Soc; 2021 Jun; 143(21):8099-8107. PubMed ID: 34014094
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effects of an Irreversible DNA Polymerase Inhibitor and DNA Damaging Agents on HeLa Cells.
Paul R; Banerjee S; Greenberg MM
ACS Chem Biol; 2017 Jun; 12(6):1576-1583. PubMed ID: 28459532
[TBL] [Abstract][Full Text] [Related]
3. Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage.
Jelezcova E; Trivedi RN; Wang XH; Tang JB; Brown AR; Goellner EM; Schamus S; Fornsaglio JL; Sobol RW
Mutat Res; 2010 Apr; 686(1-2):57-67. PubMed ID: 20096707
[TBL] [Abstract][Full Text] [Related]
4. Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping.
Hu HY; Horton JK; Gryk MR; Prasad R; Naron JM; Sun DA; Hecht SM; Wilson SH; Mullen GP
J Biol Chem; 2004 Sep; 279(38):39736-44. PubMed ID: 15258144
[TBL] [Abstract][Full Text] [Related]
5. DNA polymerase β-dependent cell survival independent of XRCC1 expression.
Horton JK; Gassman NR; Dunigan BD; Stefanick DF; Wilson SH
DNA Repair (Amst); 2015 Feb; 26():23-9. PubMed ID: 25541391
[TBL] [Abstract][Full Text] [Related]
6. Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β.
Yuhas SC; Majumdar A; Greenberg MM
Chembiochem; 2021 Aug; 22(16):2619-2623. PubMed ID: 34213836
[TBL] [Abstract][Full Text] [Related]
7. DNA polymerase beta mediates protection of mammalian cells against ganciclovir-induced cytotoxicity and DNA breakage.
Tomicic MT; Thust R; Sobol RW; Kaina B
Cancer Res; 2001 Oct; 61(20):7399-403. PubMed ID: 11606369
[TBL] [Abstract][Full Text] [Related]
8. Irreversible inhibition of DNA polymerase β by small-molecule mimics of a DNA lesion.
Arian D; Hedayati M; Zhou H; Bilis Z; Chen K; DeWeese TL; Greenberg MM
J Am Chem Soc; 2014 Feb; 136(8):3176-83. PubMed ID: 24517090
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions.
Horton JK; Joyce-Gray DF; Pachkowski BF; Swenberg JA; Wilson SH
DNA Repair (Amst); 2003 Jan; 2(1):27-48. PubMed ID: 12509266
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.
Jaiswal AS; Banerjee S; Panda H; Bulkin CD; Izumi T; Sarkar FH; Ostrov DA; Narayan S
Mol Cancer Res; 2009 Dec; 7(12):1973-83. PubMed ID: 19996303
[TBL] [Abstract][Full Text] [Related]
11. Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.
Gowda AS; Suo Z; Spratt TE
Chem Res Toxicol; 2017 Feb; 30(2):715-725. PubMed ID: 28067485
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta.
Boudsocq F; Benaim P; Canitrot Y; Knibiehler M; Ausseil F; Capp JP; Bieth A; Long C; David B; Shevelev I; Frierich-Heinecken E; Hübscher U; Amalric F; Massiot G; Hoffmann JS; Cazaux C
Mol Pharmacol; 2005 May; 67(5):1485-92. PubMed ID: 15703384
[TBL] [Abstract][Full Text] [Related]
13. DNA polymerases beta and lambda mediate overlapping and independent roles in base excision repair in mouse embryonic fibroblasts.
Braithwaite EK; Kedar PS; Stumpo DJ; Bertocci B; Freedman JH; Samson LD; Wilson SH
PLoS One; 2010 Aug; 5(8):e12229. PubMed ID: 20805875
[TBL] [Abstract][Full Text] [Related]
14. Monoacetylcurcumin: a new inhibitor of eukaryotic DNA polymerase lambda and a new ligand for inhibitor-affinity chromatography.
Mizushina Y; Ishidoh T; Takeuchi T; Shimazaki N; Koiwai O; Kuramochi K; Kobayashi S; Sugawara F; Sakaguchi K; Yoshida H
Biochem Biophys Res Commun; 2005 Dec; 337(4):1288-95. PubMed ID: 16236265
[TBL] [Abstract][Full Text] [Related]
15. DNA polymerase beta (pol β) inhibitors: a comprehensive overview.
Barakat KH; Gajewski MM; Tuszynski JA
Drug Discov Today; 2012 Aug; 17(15-16):913-20. PubMed ID: 22561893
[TBL] [Abstract][Full Text] [Related]
16. DNA polymerase beta and PARP activities in base excision repair in living cells.
Masaoka A; Horton JK; Beard WA; Wilson SH
DNA Repair (Amst); 2009 Nov; 8(11):1290-9. PubMed ID: 19748837
[TBL] [Abstract][Full Text] [Related]
17. Preventing oxidation of cellular XRCC1 affects PARP-mediated DNA damage responses.
Horton JK; Stefanick DF; Gassman NR; Williams JG; Gabel SA; Cuneo MJ; Prasad R; Kedar PS; Derose EF; Hou EW; London RE; Wilson SH
DNA Repair (Amst); 2013 Sep; 12(9):774-85. PubMed ID: 23871146
[TBL] [Abstract][Full Text] [Related]
18. Expanding the scope of human DNA polymerase λ and β inhibitors.
Strittmatter T; Brockmann A; Pott M; Hantusch A; Brunner T; Marx A
ACS Chem Biol; 2014 Jan; 9(1):282-90. PubMed ID: 24171552
[TBL] [Abstract][Full Text] [Related]
19. 5-(Hydroxymethyl)-2-furfural: a selective inhibitor of DNA polymerase lambda and terminal deoxynucleotidyltransferase.
Mizushina Y; Yagita E; Kuramochi K; Kuriyama I; Shimazaki N; Koiwai O; Uchiyama Y; Yomezawa Y; Sugawara F; Kobayashi S; Sakaguchi K; Yoshida H
Arch Biochem Biophys; 2006 Feb; 446(1):69-76. PubMed ID: 16405901
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of DNA polymerase beta: activity and mechanism.
Gao Z; Maloney DJ; Dedkova LM; Hecht SM
Bioorg Med Chem; 2008 Apr; 16(8):4331-40. PubMed ID: 18343122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
